Oxidized low-density lipoprotein depletes PKCα and attenuates reactive oxygen species formation in monocytes/macrophages

Cardiovascular Research

Volumn 71, Issue 3, 2006, Pages 574-585

  Köhl, Roman ^a   Preiß, Stefan ^a   von Knethen, Andreas ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Inflammation; Lipoproteins; Monocytes macrophages; Oxygen radicals; Protein kinase C

Indexed keywords

GO 6967; LOW DENSITY LIPOPROTEIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; INCUBATION TIME; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; PROTEIN KINASE C-ALPHA; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE;

EID: 33746308410     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.05.023     Document Type: Article

References (45)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Jonasson L., Holm J., Skalli O., Bondjers G., and Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6 (1986) 131-138
3. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 26 (2003) 1-9
4. Palinski W., Rosenfeld M.E., Yla-Herttuala S., Gurtner G.C., Socher S.S., Butler S.W., et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 86 (1989) 1372-1376
5. Frostegard J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145 (1999) 33-43
6. Raines E.W., and Ferri N. Thematic review series: the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 46 (2005) 1081-1092
7. Smith J.D., Trogan E., Ginsberg M., Grigaux C., Tian J., and Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 92 (1995) 8264-8268
8. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
9. Nguyen-Khoa T., Massy Z.A., Witko-Sarsat V., Canteloup S., Kebede M., Lacour B., et al. Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: a novel pathway in atherogenesis?. Biochem Biophys Res Commun 263 (1999) 804-809
10. Iles K.E., and Forman H.J. Macrophage signaling and respiratory burst. Immunol Res 26 (2002) 95-105
11. Bokoch G.M., and Diebold B.A. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 100 (2002) 2692-2696
12. Fontayne A., Dang P.M., Gougerot-Pocidalo M.A., and El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41 (2002) 7743-7750
13. Newton A.C. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370 (2003) 361-371
14. Dutil E.M., Toker A., and Newton A.C. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr Biol 8 (1998) 1366-1375
15. Lee H.W., Smith L., Pettit G.R., and Bingham Smith J. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin. Am J Physiol 271 (1996) C304-C311
16. Lee H.W., Smith L., Pettit G.R., Vinitsky A., and Smith J.B. Ubiquitination of protein kinase C-alpha and degradation by the proteasome. J Biol Chem 271 (1996) 20973-20976
17. Leontieva O.V., and Black J.D. Identification of two distinct pathways of protein kinase Calpha down-regulation in intestinal epithelial cells. J Biol Chem 279 (2004) 5788-5801
18. von Knethen A., Tautenhahn A., Link H., Lindemann D., and Brune B. Activation-induced depletion of protein kinase C alpha provokes desensitization of monocytes/macrophages in sepsis. J Immunol 174 (2005) 4960-4965
19. Fischer B., von Knethen A., and Brune B. Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma. J Immunol 168 (2002) 2828-2834
20. Cominacini L., Garbin U., Davoli A., Micciolo R., Bosello O., Gaviraghi G., et al. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification. J Lipid Res 32 (1991) 349-358
21. Cominacini L., Garbin U., De Santis A., Campagnola M., Davoli A., Pasini A.F., et al. Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions. J Lipid Mediat Cell Signal 13 (1996) 19-33
22. Galle J., and Wanner C. Oxidized LDL and Lp(a). Preparation, modification, and analysis. Methods Mol Biol 108 (1998) 119-130
23. Denk A., Goebeler M., Schmid S., Berberich I., Ritz O., Lindemann D., et al. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem 276 (2001) 28451-28458
24. Lindemann D., Bock M., Schweizer M., and Rethwilm A. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol 71 (1997) 4815-4820
25. Pietschmann T., Heinkelein M., Heldmann M., Zentgraf H., Rethwilm A., and Lindemann D. Foamy virus capsids require the cognate envelope protein for particle export. J Virol 73 (1999) 2613-2621
26. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23 (1995) 628-633
27. Zhao H., Joseph J., Fales H.M., Sokoloski E.A., Levine R.L., Vasquez-Vivar J., et al. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc Natl Acad Sci U S A 102 (2005) 5727-5732
28. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
29. Gaut J.P., and Heinecke J.W. Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends Cardiovasc Med 11 (2001) 103-112
30. Nagy L., Tontonoz P., Alvarez J.G., Chen H., and Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93 (1998) 229-240
31. Von Knethen A.A., and Brune B. Delayed activation of PPARgamma by LPS and IFN-gamma attenuates the oxidative burst in macrophages. FASEB J 15 (2001) 535-544
32. Minamikawa J., Tanaka S., Yamauchi M., Inoue D., and Koshiyama H. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 83 (1998) 1818-1820
33. Marx N., Libby P., and Plutzky J. Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?. J Cardiovasc Risk 8 (2001) 203-210
34. Lehrke M., and Lazar M.A. The many faces of PPARgamma. Cell 123 (2005) 993-999
35. Verrier E., Wang L., Wadham C., Albanese N., Hahn C., Gamble J.R., et al. PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. Circ Res 94 (2004) 1515-1522
36. Larsen E.C., DiGennaro J.A., Saito N., Mehta S., Loegering D.J., Mazurkiewicz J.E., et al. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J Immunol 165 (2000) 2809-2817
37. Nishizuka Y. Studies and perspectives of protein kinase C. Science 233 (1986) 305-312
38. Braun D.C., Cao Y., Wang S., Garfield S.H., Hur G.M., and Blumberg P.M. Role of phorbol ester localization in determining protein kinase C or RasGRP3 translocation: real-time analysis using fluorescent ligands and proteins. Mol Cancer Ther 4 (2005) 141-150
39. Horiuchi S., Sakamoto Y., and Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 25 (2003) 283-292
40. Cominacini L., Rigoni A., Pasini A.F., Garbin U., Davoli A., Campagnola M., et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 276 (2001) 13750-13755
41. Giardina J.B., Tanner D.J., and Khalil R.A. Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of protein kinase C isoforms alpha and epsilon. Hypertension 37 (2001) 561-568
42. Li D., Liu L., Chen H., Sawamura T., and Mehta J.L. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23 (2003) 816-821
43. Fleming I., Mohamed A., Galle J., Turchanowa L., Brandes R.P., Fisslthaler B., et al. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res 65 (2005) 897-906
44. Meier M., and King G.L. Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc Med 5 (2000) 173-185
45. Idris I., Gray S., and Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44 (2001) 659-673